Dora Visky

Senior Director, Analytical Development and CMC Leadership at iVIEW Therapeutics

Dora Visky has a diverse work experience in the pharmaceutical industry spanning over several companies and roles. Dora started their career at Johnson & Johnson Pharmaceutical Research & Development as a Scientist in Analytical Development, where they actively contributed to regulatory filings and managed analytical development aspects of drug development projects. Dora later became a Senior Scientist, further enhancing their expertise in analytical methods and stability data.

After their time at Johnson & Johnson, Dora joined Celgene as a Principal Scientist/Senior Scientist. Here, they led a cross-functional team in designing and developing the first oral sprinkle pediatric product for the company. Dora also served as an Analytical Development Project Leader and Group Leader, collaborating with development scientists and leading analytical development teams.

Following their tenure at Celgene, Dora joined Ferring Pharmaceuticals as a Director in Analytical Development. In this role, they were responsible for managing all Analytical Development activities for the US portfolio of products. Dora worked closely with various departments to ensure clinical and regulatory success, while also leading a team of scientists and driving pipeline advancement.

Next, Dora joined Praxis Precision Medicines, Inc. as a Senior Director in Analytical Development / CMC. Dora provided strategic and technical leadership to the CMC Team for an oligonucleotide asset, overseeing drug substance supply, drug product design, and manufacturing, as well as analytical development and testing. Dora also established the Analytical Chemistry function for Praxis.

Most recently, Dora joined IView Therapeutics as a Senior Director in Analytical Development and CMC Leadership. Dora is responsible for all Analytical Development deliverables for the company's four assets. Additionally, they serve as the CMC Leader for iVIEW-1001, overseeing product design, development, and selection of DP GMP manufacturing CMO for a unique dosage form.

Throughout their career, Dora has demonstrated strong leadership skills, resource management, and the ability to proactively identify and mitigate risks. Dora has a track record of successfully advancing projects, managing budgets, and collaborating with cross-functional teams in the pharmaceutical industry.

Dora Visky's education history includes pursuing a Master's degree in Pharmacy from Semmelweis University. Additionally, they also pursued a Doctor of Philosophy - PhD in Pharmaceutical Sciences, with a field of study in Analytical Chemistry at Semmelweis University. However, no specific start or end years are provided for these educational pursuits.

Links

Previous companies

Ferring Pharmaceuticals logo


Teams

This person is not in any teams